Antimicrobial Agents Practice Questions

Q: Even in large dosages used in malaria, quinine does not cause toxicity because why?

Elevated plasma alpha acid glycoprotein. ### Explanation The correct answer is **B. Elevated plasma alpha acid glycoprotein.** **Mechanism and Concept:** Quinine is a basic drug that primarily binds to **Alpha-1 Acid Glycoprotein (AAG)** in the plasma. In patients with acute malaria, AAG levels significantly increase because it is an "acute-phase reactant." This elevation leads to an increase in the protein-bound fraction of quinine, thereby **decreasing the free (unbound) fraction** of the drug in the plasma. Since only the free drug is pharmacologically active and capable of causing toxicity, the elevated AAG acts as a protective buffer, allowing patients to tolerate high dosages without experiencing severe side effects like cinchonism. **Why other options are incorrect:** * **A. It enters in fat cells:** Quinine is not highly lipophilic; it has a large volume of distribution but primarily binds to tissues like the liver, kidneys, and muscles, not specifically fat cells. * **C. Deposited in infected RBCs:** While quinine does concentrate in erythrocytes to exert its antimalarial effect, this sequestration is not the primary mechanism that prevents systemic toxicity. * **D. Excreted rapidly in urine:** Quinine is primarily metabolized by the liver (CYP3A4). Only a small fraction is excreted unchanged in the urine, and its half-life is actually prolonged in severe malaria. **High-Yield Clinical Pearls for NEET-PG:** * **Acidic drugs** (e.g., NSAIDs, Warfarin, Phenytoin) bind primarily to **Albumin**. * **Basic drugs** (e.g., Quinine, Lidocaine, Propranolol) bind primarily to **Alpha-1 Acid Glycoprotein**. * **Cinchonism:** The classic triad of quinine toxicity includes tinnitus, visual disturbances, and headache. * **Hypoglycemia:** A common side effect of quinine due to the stimulation of pancreatic beta cells to release insulin.

Q: Which antibiotic acts by interfering with the addition of new cell wall subunits (muramyl pentapeptides)?

Vancomycin. ### Explanation **Correct Option: C. Vancomycin** Vancomycin is a glycopeptide antibiotic that inhibits bacterial cell wall synthesis by binding to the **D-Ala-D-Ala** terminus of the nascent peptidoglycan precursor (muramyl pentapeptide). This binding creates a "steric hindrance" that prevents the **transglycosylase** enzyme from adding new subunits to the growing peptidoglycan chain. By interfering with the addition of these subunits, it halts the elongation of the cell wall. **Analysis of Incorrect Options:** * **A. Bacitracin:** Inhibits cell wall synthesis by interfering with the **dephosphorylation of the lipid carrier (bactoprenol)**, which transports peptidoglycan subunits across the cell membrane. It does not bind to the subunits themselves. * **B. Penicillins:** These are Beta-lactams that inhibit the **transpeptidase** enzyme (Penicillin Binding Proteins). They prevent the **cross-linking** of peptidoglycan chains rather than the addition of new subunits. * **C. Mupirocin:** This is a protein synthesis inhibitor. It acts by binding to bacterial **isoleucyl-tRNA synthetase**, preventing the incorporation of isoleucine into nascent proteins. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Resistance:** The most common mechanism for Vancomycin resistance (e.g., VRSA/VRE) is the alteration of the binding site from **D-Ala-D-Ala to D-Ala-D-Lac**. * **Red Man Syndrome:** A common infusion-related reaction caused by direct histamine release (not a true IgE-mediated allergy). It is managed by slowing the infusion rate. * **Spectrum:** Vancomycin is active only against **Gram-positive** bacteria (it is too large to pass through the porins of Gram-negative outer membranes). * **Drug of Choice:** It remains the gold standard for **MRSA** (Methicillin-resistant *Staphylococcus aureus*).

Q: Ritonavir boosting is not recommended with which of the following protease inhibitors of HIV?

Nelfinavir. **Explanation:** The concept of **"Ritonavir Boosting"** relies on the ability of Ritonavir to act as a potent inhibitor of the **CYP3A4 enzyme**. By inhibiting this enzyme, Ritonavir slows the metabolism of co-administered Protease Inhibitors (PIs), leading to higher plasma concentrations, a longer half-life, and reduced dosing frequency. **Why Nelfinavir is the Correct Answer:** Nelfinavir is the only Protease Inhibitor that is **not** boosted by Ritonavir. Unlike other PIs, Nelfinavir is primarily metabolized by **CYP2C19** (and to a lesser extent by CYP3A4 and CYP2C9). Furthermore, Nelfinavir’s active metabolite (M8) is also potent. Because its primary metabolic pathway is not CYP3A4-dependent, adding Ritonavir does not significantly increase its plasma levels to a clinically beneficial degree. **Analysis of Incorrect Options:** * **Darunavir & Lopinavir:** These are "second-generation" PIs that are almost always administered with Ritonavir. In fact, Lopinavir is only available as a fixed-dose combination with Ritonavir (Kaletra) because its bioavailability is too poor otherwise. * **Saquinavir:** This was the first PI developed. It has very low oral bioavailability, which is significantly improved (boosted) when combined with Ritonavir. **High-Yield Clinical Pearls for NEET-PG:** * **Lopinavir/Ritonavir:** The "Gold Standard" for boosted PI therapy, often used in second-line ART regimens. * **Adverse Effects:** PIs are classically associated with **Lipodystrophy** (buffalo hump), **Hyperlipidemia**, and **Insulin Resistance**. * **Nelfinavir Specifics:** It is frequently associated with **diarrhea** as a major side effect. * **Atazanavir:** Another PI that requires boosting; it is unique for causing unconjugated hyperbilirubinemia (benign jaundice).

Q: What is the drug of choice for Falciparum Malaria?

Artemisinin-based Combination Therapy (ACT). **Explanation:** The management of malaria is a high-yield topic for NEET-PG, focusing on drug resistance patterns and current WHO/National guidelines. **Why ACT is the Correct Answer:** **Artemisinin-based Combination Therapy (ACT)** is currently the global drug of choice for **uncomplicated *Plasmodium falciparum* malaria**. The rationale behind using a combination (e.g., Artesunate + Sulfadoxine-Pyrimethamine or Artemether + Lumefantrine) is twofold: 1. **Rapid Clearance:** Artemisinins are the fastest-acting schizontocides, reducing the parasite biomass rapidly. 2. **Resistance Prevention:** The longer-acting partner drug eliminates residual parasites, preventing the development of resistance to artemisinin. **Analysis of Incorrect Options:** * **A. Chloroquine:** While it remains the drug of choice for *P. vivax*, it is no longer used for *P. falciparum* due to widespread **high-level resistance** (mutations in the *pfcrt* gene). * **B. Mefloquine:** Used primarily for prophylaxis in travelers or as a component of certain ACTs (Artesunate + Mefloquine), but it is not the first-line monotherapy due to neuropsychiatric side effects. * **D. Proguanil:** Usually used in combination with Atovaquone (Malarone) for prophylaxis or treatment in specific regions, but it is not the standard first-line recommendation for *falciparum* in endemic areas like India. **Clinical Pearls for NEET-PG:** * **Severe/Complicated Malaria:** The drug of choice is **Intravenous (IV) Artesunate**. * **Pregnancy:** ACT is now recommended for *falciparum* malaria in **all trimesters** (including the first). * **Gametes:** Artemisinins have gametocytocidal action against *P. falciparum*, helping reduce transmission. * **India Specific:** In India, the preferred ACT is **Artesunate + Sulfadoxine-Pyrimethamine (AS+SP)**, except in North-Eastern states where **Artemether + Lumefantrine** is used due to SP resistance.

Q: Which anti-malarial drugs are effective in the pre-erythrocytic phase in the liver?

Proguanil. **Explanation:** Anti-malarial drugs are classified based on the stage of the *Plasmodium* life cycle they target. The **pre-erythrocytic (exo-erythrocytic) phase** occurs in the liver immediately after a mosquito bite, before the parasites enter the bloodstream. **1. Why Proguanil is Correct:** Proguanil (and its active metabolite cycloguanil) acts as a **causal prophylactic** agent. It inhibits the enzyme dihydrofolate reductase (DHFR), disrupting DNA synthesis in the primary liver stages of both *P. falciparum* and *P. vivax*. This prevents the infection from ever reaching the red blood cells. It is often used in combination with Atovaquone (Malarone) for this purpose. **2. Why the Incorrect Options are Wrong:** * **Chloroquine:** It is a potent **blood schizonticide**. It acts by inhibiting heme polymerase in the erythrocytic stage but has no activity against liver stages. * **Pyrimethamine:** While it also inhibits DHFR, it is primarily effective against the erythrocytic stages and is used as a **slow-acting blood schizonticide** (usually combined with Sulfadoxine). It is not typically used for causal prophylaxis. * **Quinine:** An alkaloid that acts as a rapid **blood schizonticide**. It is used for severe malaria but lacks activity against any hepatic stages. **High-Yield NEET-PG Pearls:** * **Causal Prophylactics (Liver stage):** Proguanil, Primaquine, and Pyrimethamine (weakly). * **Radical Cure (Hypnozoites):** Primaquine and Tafenoquine are the only drugs that kill dormant liver stages (*P. vivax/ovale*). * **Drug of Choice for Pregnancy:** Chloroquine (if sensitive); Quinine is safe for severe malaria in all trimesters. * **Proguanil Side Effect:** Mouth ulcers (stomatitis) are a characteristic adverse effect.

Q: Which of the following antibiotics are safe to treat urinary tract infections in pregnancy?

Penicillins and Cephalosporins. ### Explanation **1. Why Penicillins and Cephalosporins are Correct:** In pregnancy, drug safety is categorized based on the potential risk to the fetus. **Penicillins** (e.g., Amoxicillin, Ampicillin) and **Cephalosporins** (e.g., Cephalexin, Ceftriaxone) are considered **Category B** drugs. They are the first-line agents for treating Urinary Tract Infections (UTIs) because they lack teratogenic potential and have a high therapeutic index. Their mechanism of action—inhibiting bacterial cell wall synthesis—targets a process absent in human cells, making them exceptionally safe for both the mother and the developing fetus. **2. Why Other Options are Incorrect:** * **Aminoglycosides (Options A & B):** These are contraindicated (Category D) as they can cause **fetal ototoxicity** (damage to the 8th cranial nerve) and potential nephrotoxicity. * **Fluoroquinolones/Ciprofloxacin (Options B & D):** These are avoided in pregnancy because they have a high affinity for bone and cartilage, potentially leading to **arthropathy** and permanent cartilage damage in the fetus. * **Cotrimoxazole (Option D):** This is a combination of Sulfonamides and Trimethoprim. Trimethoprim is a **folate antagonist** (risk of neural tube defects in the 1st trimester), and Sulfonamides can displace bilirubin from albumin, leading to **kernicterus** in the newborn if used near term. **3. NEET-PG High-Yield Pearls:** * **Nitrofurantoin:** Safe in the 2nd trimester but contraindicated at term (38-42 weeks) due to the risk of **hemolytic anemia** in the newborn (due to immature G6PD enzymes). * **Fosfomycin:** A single-dose safe alternative for uncomplicated cystitis in pregnancy. * **Asymptomatic Bacteriuria:** In pregnancy, this **must** always be treated to prevent progression to pyelonephritis and preterm labor.

Q: What is the drug of choice for dysentery caused by Shigella?

Ciprofloxacin. **Shigellosis (Bacillary Dysentery)** is characterized by high-grade fever, abdominal cramps, and frequent small-volume stools containing blood and mucus. The primary goal of treatment is to reduce the duration of illness and prevent person-to-person transmission. **Why Ciprofloxacin is the Correct Answer:** Fluoroquinolones, specifically **Ciprofloxacin**, are currently the **drug of choice (DOC)** for Shigella dysentery in both adults and children, as recommended by the WHO. They are highly effective because they achieve high concentrations in the intestinal mucosa and are bactericidal against most *Shigella* species. In cases of resistance, Ceftriaxone or Azithromycin are used as alternatives. **Analysis of Incorrect Options:** * **A & C (Doxycycline/Tetracycline):** While tetracyclines were used historically, widespread plasmid-mediated resistance has rendered them ineffective against most *Shigella* strains globally. * **D (No antibiotic recommended):** Unlike *Salmonella* gastroenteritis (where antibiotics may prolong the carrier state), *Shigella* is an invasive pathogen. Antibiotics are **strongly recommended** for all cases of suspected shigellosis to limit the clinical course and reduce the risk of complications like HUS (Hemolytic Uremic Syndrome). **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Ciprofloxacin inhibits **DNA Gyrase (Topoisomerase II)** and Topoisomerase IV, preventing bacterial DNA replication [1]. * **Pediatric Note:** Although fluoroquinolones are generally avoided in children due to potential cartilage damage, they are the **DOC for pediatric shigellosis** because the benefits outweigh the risks. * **Avoid Antimotility Agents:** Loperamide is **contraindicated** in Shigella dysentery as it can worsen the infection and increase the risk of toxic megacolon.

Q: Which one of the following drugs may be used for prevention of relapse of P. vivax infection?

Primaquine. **Explanation:** The correct answer is **Primaquine**. **1. Why Primaquine is correct:** *Plasmodium vivax* and *P. ovale* have a unique life cycle stage called the **hypnozoite** (latent form) that remains dormant in the liver. These hypnozoites can "wake up" months or years later, causing a clinical **relapse**. Primaquine is a tissue schizonticide and is the only widely used drug effective against these hepatic hypnozoites. This process of clearing the liver stage to prevent relapse is known as **Radical Cure**. **2. Why the other options are incorrect:** * **Chloroquine:** It is a potent blood schizonticide. While it is the drug of choice for treating the erythrocytic (symptomatic) stage of sensitive *P. vivax*, it has no effect on the liver hypnozoites and therefore cannot prevent relapse. * **Atovaquone:** Primarily used in combination with Proguanil (Malarone) for prophylaxis and treatment of chloroquine-resistant *P. falciparum*. It acts on the mitochondrial electron transport chain but is not used for the radical cure of *P. vivax*. * **Tetracycline:** Acts as a slow-acting blood schizonticide by inhibiting protein synthesis. It is used as an adjunct to quinine in resistant *P. falciparum* cases, not for preventing relapses. **High-Yield Clinical Pearls for NEET-PG:** * **G6PD Deficiency:** Before prescribing Primaquine, patients **must** be screened for G6PD deficiency, as the drug can cause severe **acute hemolytic anemia** in these individuals. * **Pregnancy:** Primaquine is **contraindicated** in pregnancy because the fetus is relatively G6PD deficient. * **Tafenoquine:** A newer long-acting analog of Primaquine that can be used as a single dose for radical cure. * **Recrudescence vs. Relapse:** Relapse (Vivax/Ovale) is due to hypnozoites; Recrudescence (Falciparum/Malariae) is due to the survival of erythrocytic forms due to inadequate treatment.

Q: Which of the following penicillins is effective against Pseudomonas?

Piperacillin. **Explanation:** **1. Why Piperacillin is Correct:** Piperacillin belongs to the **Extended-spectrum penicillins** (specifically the Ureidopenicillins). These agents are specifically designed to penetrate the outer membrane of Gram-negative bacteria, including *Pseudomonas aeruginosa*. It inhibits cell wall synthesis by binding to penicillin-binding proteins (PBPs). In clinical practice, it is almost always combined with the beta-lactamase inhibitor **Tazobactam** (Zosyn) to broaden its coverage against resistant strains. **2. Why the Other Options are Incorrect:** * **Amoxicillin & Ampicillin:** These are **Aminopenicillins**. While they have better Gram-negative coverage than Penicillin G (e.g., *E. coli, H. influenzae*), they are completely ineffective against *Pseudomonas* because they cannot penetrate its complex outer membrane and are easily degraded by its beta-lactamases. * **Oxacillin:** This is an **Antistaphylococcal penicillin** (along with Nafcillin and Methicillin). Its narrow spectrum is specifically targeted toward *Staphylococcus aureus* (MSSA). It has no significant activity against Gram-negative organisms like *Pseudomonas*. **3. High-Yield Clinical Pearls for NEET-PG:** * **Anti-Pseudomonal Penicillins:** Remember them using the mnemonic **"TCP"**: **T**icarcillin (Carboxypenicillin), **C**arbenicillin, and **P**iperacillin (Ureidopenicillin). * **Potency:** Piperacillin is the most potent anti-pseudomonal penicillin. * **Other Anti-Pseudomonal Drugs:** * **Cephalosporins:** Ceftazidime (3rd gen) and Cefepime (4th gen). * **Carbapenems:** Imipenem, Meropenem, and Doripenem (**Note:** Ertapenem does *not* cover Pseudomonas). * **Monobactams:** Aztreonam. * **Fluoroquinolones:** Ciprofloxacin and Levofloxacin. * **Aminoglycosides:** Amikacin, Gentamicin, and Tobramycin.

Q: Which of the following drugs is NOT a cell wall synthesis inhibitor?

Colistin. The correct answer is **Colistin**. To answer this question correctly, one must distinguish between drugs that inhibit the **synthesis** of the cell wall and those that disrupt the **integrity** of the cell membrane. **1. Why Colistin is the correct answer:** Colistin (Polymyxin E) is a **cell membrane disruptor**, not a cell wall synthesis inhibitor. It acts like a cationic detergent. It binds to lipopolysaccharides (LPS) and phospholipids in the outer membrane of Gram-negative bacteria, displacing calcium and magnesium ions. This leads to increased permeability, leakage of intracellular contents, and rapid cell death. [1] **2. Why the other options are incorrect:** All other options inhibit specific steps in the complex process of peptidoglycan (cell wall) synthesis: * **Fosfomycin:** Inhibits the enzyme **Enolpyruvate transferase (MurA)**, blocking the conversion of NAG to NAM. This is the earliest step in cell wall synthesis (cytoplasmic phase). * **Cycloserine:** A structural analog of D-alanine, it inhibits **L-alanine racemase** and **D-alanyl-D-alanine synthetase**, preventing the formation of the D-Ala-D-Ala dipeptide. [3] * **Bacitracin:** Inhibits the **dephosphorylation of C55-isoprenyl pyrophosphate** (bactoprenol), the lipid carrier that transports peptidoglycan subunits across the cell membrane. [2, 3] **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Cell Wall Inhibitors:** "**P**enicillins **C**an **B**lock **F**ormation" (**P**enicillins/Cephalosporins, **C**ycloserine, **B**acitracin, **F**osfomycin) + Vancomycin. * **Colistin Toxicity:** It is highly nephrotoxic and neurotoxic; it is often used as a "last-resort" drug for Multi-Drug Resistant (MDR) Gram-negative infections like *Pseudomonas* and *Acinetobacter*. * **Fosfomycin** is a first-line drug for uncomplicated UTIs due to its high concentration in urine.

Question 1

Even in large dosages used in malaria, quinine does not cause toxicity because why?

Accepted Answer

Elevated plasma alpha acid glycoprotein

Answer

It enters in fat cells

Answer

Deposited in infected RBCs

Answer

Excreted rapidly in urine

Question 2

Which antibiotic acts by interfering with the addition of new cell wall subunits (muramyl pentapeptides)?

Accepted Answer

Vancomycin

Answer

Bacitracin

Answer

Penicillins

Answer

Mupirocin

Question 3

Ritonavir boosting is not recommended with which of the following protease inhibitors of HIV?

Accepted Answer

Nelfinavir

Answer

Darunavir

Answer

Saquinavir

Answer

Lopinavir

Question 4

What is the drug of choice for Falciparum Malaria?

Accepted Answer

Artemisinin-based Combination Therapy (ACT)

Answer

Chloroquine

Answer

Mefloquine

Answer

Proguanil

Question 5

Which anti-malarial drugs are effective in the pre-erythrocytic phase in the liver?

Accepted Answer

Proguanil

Answer

Chloroquine

Answer

Pyrimethamine

Answer

Quinine

Question 6

Which of the following antibiotics are safe to treat urinary tract infections in pregnancy?

Accepted Answer

Penicillins and Cephalosporins

Answer

Aminoglycosides and Penicillins

Answer

Aminoglycosides and Ciprofloxacin

Answer

Cotrimoxazole and Ciprofloxacin

Question 7

What is the drug of choice for dysentery caused by Shigella?

Accepted Answer

Ciprofloxacin

Answer

Doxycycline

Answer

Tetracycline

Answer

No antibiotic is recommended

Question 8

Which one of the following drugs may be used for prevention of relapse of P. vivax infection?

Accepted Answer

Primaquine

Answer

Chloroquine

Answer

Atovaquone

Answer

Tetracycline

Question 9

Which of the following penicillins is effective against Pseudomonas?

Accepted Answer

Piperacillin

Answer

Amoxicillin

Answer

Ampicillin

Answer

Oxacillin

Question 10

Which of the following drugs is NOT a cell wall synthesis inhibitor?

Accepted Answer

Colistin

Answer

Fosfomycin

Answer

Bacitracin

Answer

Cycloserine

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?